Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gan & Lee Pharmaceutical

Request full access

Gan & Lee pharmaceutical is a Chinese high-tech biopharmaceutical company engaged in the R&D of insulin glargine and insulin lispro

Dongcheng District, ChinaFounded 1998Biotech & Life Sciences

About Gan & Lee Pharmaceutical

Gan Lee Pharmaceuticals, headquartered in Beijing, is a leading Chinese pharmaceutical company specializing in the development, production, and commercialization of insulin analogs and medical devices. Founded in 1998, Gan Lee has grown to employ over 4,000 people globally and operates an industrial park spanning approximately 200,000 square meters. The company is renowned for developing the first Chinese domestic insulin analog and has a series of insulin products approved in China. Gan Lee's market extends internationally, with its products available in countries such as Egypt, Pakistan, and Mexico. The company has also established subsidiaries in New Jersey, USA, and Hong Kong, China, to bolster its global business development and production capabilities. Gan Lee serves a diverse clientele, including healthcare providers and patients requiring insulin therapy. The company operates within the biopharmaceutical market, focusing on innovative solutions for diabetes management. Gan Lee's business model revolves around research and development, manufacturing, and sales of its pharmaceutical products, generating revenue through both domestic and international markets. The company's commitment to innovation and quality has earned it numerous accolades, including the 2021 Outstanding Industrial Contribution Award for China Listed Companies and the 2021 Evergreen Award for Innovative Pharmaceutical Company of the Year.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1998
Headquarters
Dongcheng District, China
Employees
489
Open positions
2
Dealroom signal
36.2/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Diabetes, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Investment activity
1 company, latest Nov 2021
Capital deployed
$69M
Preferred round
SERIES D
Links
Website

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPO✓Exit Jun 2020 $360M $5B Undisclosed —
GROWTH EQUITY VC✓Equity / VC Nov 2014 — $1.5B Qiming Venture Partners · Goldman Sachs · Hillhouse Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Gan & Lee Pharmaceutical website traffic

Latest recorded traffic for Gan & Lee Pharmaceutical is 3.8K monthly website visits, up 35.7% over the last three months. Gan & Lee Pharmaceutical's team grew 0% over the past year.

Latest monthly visits3.8K 3-month web change+35.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gan & Lee Pharmaceutical in the Dongcheng District ecosystem

Live from Dealroom

The Gan & Lee Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later1 investor entered at this stage

Other known investors1 additional known investor

  • Peking University
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Dongcheng District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gan & Lee Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gan & Lee Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.